Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v8-EN
Language English English
Date Updated 2018-06-09 2018-05-29
Drug Identification Number 02269066 02269066
Brand name LUVERIS LUVERIS
Common or Proper name Lutropin Alpha for injection Lutropin Alpha for injection
Company Name EMD SERONO, A DIVISION OF EMD INC., CANADA EMD SERONO, A DIVISION OF EMD INC., CANADA
Ingredients LUTROPIN ALFA LUTROPIN ALFA
Strength(s) 75UNIT 75UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 x 75 IU vial 1 x 75 IU vial
ATC code G03GA G03GA
ATC description GONADOTROPHINS AND OTHER OVULATION STIMULANTS GONADOTROPHINS AND OTHER OVULATION STIMULANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-05-28 2018-05-28
Estimated end date 2018-06-11
Actual end date 2018-06-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments